In mid-2021, the Patient Safety Programme (PSP) office was established in the National Quality and Patient Safety Directorate to oversee and monitor implementation of the Patient Safety Strategy 2019 – 2024 . The PSP Office is positioned to act as a central hub for implementation information, shared learning and resources. Its key functions are to:
- Provide leadership that facilitates the implementation of the Patient Safety Strategy;
- Support Strategy implementation through programme management and monitoring as relates to the Commitments and Actions outlined in the Strategy;
- Foster a culture of learning and education to build capacity and capability in Quality and Patient Safety (QPS), to support Strategy implementation;
- Provide communication around the Strategy that informs, connects and supports; and
- Report on implementation priorities and progress to the National Clinical Director QPS.
International evidence indicates there are a small number of high impact patient safety risks, which, if tackled effectively, can result in improving safety and quality across all health settings. Considering this evidence, thirteen patient safety priority areas, referred to as “common causes of harm” have been identified in the Patient Safety Strategy.
Events and Learning
Connect with us
Maria Lordan Dunphy, Assistant National Director and Programme Lead, Patient Safety Programme
Róisín Egenton, Programme Manager (Strategy), Patient Safety Programme
Dervla Hogan, Programme Manager (Operations), Patient Safety Programme
Ciara Kirke, Clinical Lead, Medication Safety Programme
Muriel Pate, Medication Safety Specialist Pharmacist, Medication Safety Programme